Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
---|---|---|---|---|---|---|---|
1. | Downregulation of NAD(P)H:Quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells | Kukongviriyapan, V. Senggunprai, L. Kongpetch, S. Zeekpudsa, P. Prawan, A. |
2017 | ||||
2. | All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells | Butsri, S. Kukongviriyapan, V. Senggunprai, L. Kongpetch, S. Prawan, A. |
2022 | Count | 2 | 0 | 0 | 0 |
Title | Authors | Year | Publication name | Cited count | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | ||||||
1. | Downregulation of NAD(P)H:Quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells | Kukongviriyapan, V. Senggunprai, L. Kongpetch, S. Zeekpudsa, P. Prawan, A. |
2017 |
Oncology Letters 6 (13), pp. 4540-4548 |
||||||||
2. | All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells | Butsri, S. Kukongviriyapan, V. Senggunprai, L. Kongpetch, S. Prawan, A. |
2022 |
Oncology Letters 6 (23), pp. |
Title | Authors | Year | Journal title |
---|
Title | Authors | Year | Journal title | Cited count | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total |
Title | Authors | Year | Journal title |
---|
Title | Authors | NRIIS type | Year | NRIIS Scholarship |
---|